Volume 23, Issue 4, Pages 709-727 (August 2009)
8 of 17
ABSTRACT
FULL TEXT
FULL-TEXT PDF (855 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
DOWNLOAD IMAGES
NEED REPRINTS?
BOOKMARK ARTICLE
FULL TEXT ELSEWHERE
Plasma cell myeloma is a heterogenous disease with variable clinical presentation and outcome. The prognosis is largely determined by tumor biology. Newer therapeutic agents are rapidly changing the survival outlook of myeloma patients.
Department of Hematopathology, Box 72, University of Texas-MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77070, USA
PII: S0889-8588(09)00088-4
doi:10.1016/j.hoc.2009.04.012
© 2009 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
ABSTRACT